Search
Close this search box.
    • Small Molecules
      • Discovery
        Development
        Manufacturing
    • Biologics
      • Discovery
        Development & Manufacturing
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery

      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma

      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers

      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)

      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

    • Investors
      Corporate Governance
  • Careers
Search
Close this search box.

Disclosures under Regulation 46 of the LODR

KMP authorized for determining materiality of events/information
Open
About Syngene
Open
Terms and conditions of appointment of Independent Directors
Open
Composition of committees of board of directors
Open
Code of ethics & business conduct
Open
Code of conduct for Independent Directors
Open
Whistle Blower Policy
Open
Policy on Related Party Transactions
Open
Policy for determining 'material' subsidiaries
Open
Familiarisation Policy and Details of Familiarisation Programme
Open
Contact details for queries/grievance redressal
Open
Contact details of designated officals for Investor Grievances
Open
Financial Information
Open
Shareholding Pattern
Open
Analyst & Investor Meets
Open
Quarterly Investors Call
Open
Newspaper publications
Open
Credit Ratings
Open
Subsidiary Financials
Open
Annual Secretarial Compliance Report
Open
Policy on determination of materiality of events
Open
Disclosures under Regulation 30
Open
Dividend Distribution Policy
Open
Annual Return
Open

Sign-up for our newsletter

© 2024. Syngene International Limited

Linkedin-in Youtube Facebook-f

Quick links

Business

Get in touch

Other links

Linkedin-in Youtube Facebook-f

© 2024. Syngene International Limited

Download PDF
Download PDF

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

Close

To view or email, Please share your details view

To download, Please share your details